Parmax Pharma Ltd — Updates, 14-08-2025: Company Update

The Board of Directors of Parmax Pharma Limited has appointed Mr. Samsad Alam Khan as the Secretarial Auditor for a five-year term, covering FY 2025-26 to FY 2029-30. This appointment is contingent on approval by shareholders at the upcoming Annual General Meeting. Mr. Khan is a Practicing Company Secretary with over 13 years of experience in corporate law and compliance. This strategic move strengthens the company's governance framework and regulatory adherence, which is vital for maintaining stakeholder confidence.